Cerner Corp (CERN)

Cerner Corp (NASDAQ:CERN) ranks in the top 10% of its industry group, Health Care Technology, and in the top decile of sector group, Health Care, with a market value of $23.3 billion. From an investment attractiveness vantage point, CERN is ranked in the top half of the sector with a ranking of 220 among the 782 companies in the sector; the ranking for CERN by Portfolio Grader places it 8 among the 24 companies in this industry group, placing it in the top half and number 1,203 in the 5000 company Portfolio Grader company universe.

Cerner Corp (NASDAQ:CERN) ranks in the top 10% of its industry group, Health Care Technology, and in the top decile of sector group, Health Care, with a market value of $23.3 billion. From an investment attractiveness vantage point, CERN is ranked in the top half of the sector with a ranking of 220 among the 782 companies in the sector; the ranking for CERN by Portfolio Grader places it 8 among the 24 companies in this industry group, placing it in the top half and number 1,203 in the 5000 company Portfolio Grader company universe.

Cerner Corp (NASDAQ:CERN) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

The current recommendation of Buy for Cerner Corp (NASDAQ:CERN) is the result of using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

The current recommendation of Buy for Cerner Corp (NASDAQ:CERN) is computed using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The shares have been upgraded from a Hold to a Buy in the last week.

Portfolio Grader currently ranks Cerner Corp (NASDAQ:CERN) a Buy. Using Louis Navellier's investing methods, this analytical tool researches stocks by employing proprietary fundamental and quantitative metrics. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Portfolio Grader currently ranks Cerner Corp (NASDAQ:CERN) a Hold. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool researches nearly 5,000 stocks weekly. CERN has been downgraded from a Buy to a Hold in the last week.

Cerner Corp (NASDAQ:CERN) is one of the 782 companies in the GICS Health Care sector, and a constituent of the 26 company Health Care Technology GICS industry group within this sector. CERN's market value is $24.2 billion which falls in the top decile in its industry group. Portfolio Grader's current ranking for CERN puts it 7 among the 26 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 167 among the 782 companies in the sector, and number 1,198 in the nearly 5,000 company Portfolio Grader universe.

As one of the 783 companies in the GICS Health Care sector Cerner Corp (NASDAQ:CERN) is a member of the 26 company Health Care Technology GICS industry group within this sector. CERN has a market value of $24.4 billion which is in the top 10% of its industry group. The ranking for CERN by Portfolio Grader places it 9 among the 26 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 226 among the 783 companies in the sector, and number 1,629 in the nearly 5,000 company Portfolio Grader universe.

Currently, Cerner Corp (NASDAQ:CERN) has a Hold using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CERN has had from Portfolio Grader for 5 months.

Currently, Cerner Corp (NASDAQ:CERN) has a Hold using Louis Navellier's system for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking CERN has had from Portfolio Grader for 5 months.